IPMN cyst database to help predict pancreatic cancer risk
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult age 18 to 90 years old
- Have pancreatic cysts on imaging that look like IPMN
- Have been identified as having an IPMN-consistent cystic mass
- Not formally decline enrolling in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.
This study follows people with small, low-risk pancreatic cysts to see if they can be safely monitored without surgery. It aims to confirm that watching these cysts closely is a good alternative to immediate treatment.
This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.
This study looks at how GLP-1 receptor agonist medicines (commonly used for diabetes or weight loss) affect a type of pancreatic cyst called IPMN. If you have IPMN and take this type of medicine, your data may help doctors understand whether it changes the cyst's behavior.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This study looks at people with a type of pancreatic cyst called an IPMN. Doctors want to see if measuring how well your pancreas makes digestive enzymes can help predict how the cyst will progress. Taking part may help tailor your monitoring and catch problems earlier.
Hear when a new IPMN, Pancreatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.